{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:56:57Z","timestamp":1788447417130,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Choline kinase (CK) is reportedly overexpressed in various malignancies. Among its isoforms, CK\u03b1 overexpression is presumably related to oncogenic change. Choline positron emission tomography (PET) is reportedly useful for detecting and evaluating therapy outcomes in malignancies. In this study, we investigated the correlation between CK\u03b1 expression and <jats:sup>11<\/jats:sup>C-choline accumulation in breast cancer cells. We also compared the CK\u03b1 expression level with other pathological findings for investigating tumour activity. Fifty-six patients with breast cancer (mean age: 51\u00a0years) who underwent their first medical examination between May 2007 and December 2008 were enrolled. All the patients underwent <jats:sup>11<\/jats:sup>C-choline PET\/computed tomography imaging prior to surgery. The maximum standardised uptake value was recorded for evaluating <jats:sup>11<\/jats:sup>C-choline accumulation. The intensity of CK\u03b1 expression was classified using immunostaining. A significant correlation was observed between CK\u03b1 expression and <jats:sup>11<\/jats:sup>C-choline accumulation (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). A comparison of breast cancer mortality demonstrated that strong CK\u03b1 expression was associated with a shorter survival time (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). <jats:sup>11<\/jats:sup>C-choline accumulation was also negatively correlated with survival time (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Tumours with strong CK\u03b1 expression are reportedly highly active in breast cancer. A correlation was observed between CK\u03b1 expression and <jats:sup>11<\/jats:sup>C-choline accumulation, suggesting their role as prognostic indicators of breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-023-44542-4","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:03:19Z","timestamp":1697536999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation between choline kinase alpha expression and 11C-choline accumulation in breast cancer using positron emission tomography\/computed tomography: a retrospective study"],"prefix":"10.1038","volume":"13","author":[{"given":"Akane","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"1\u20132","key":"44542_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0005-2760(97)00118-5","volume":"1348","author":"K Ishidate","year":"1997","unstructured":"Ishidate, K. Choline\/ethanolamine kinase from mammalian tissues. Biochim. Biophys. Acta. 1348(1\u20132), 70\u201378 (1997).","journal-title":"Biochim. Biophys. Acta."},{"issue":"18","key":"44542_CR2","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-04-0489","volume":"64","author":"A Ram\u00edrez de Molina","year":"2004","unstructured":"Ram\u00edrez de Molina, A. et al. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res. 64(18), 6732\u20136739 (2004).","journal-title":"Cancer Res."},{"issue":"3","key":"44542_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","volume":"296","author":"A Ramirez de Molina","year":"2002","unstructured":"Ramirez de Molina, A. et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem. Biophys. Res. Commun. 296(3), 580\u2013583 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"44542_CR4","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1038\/sj.onc.1205556","volume":"21","author":"A Ram\u00edrez de Molina","year":"2002","unstructured":"Ram\u00edrez de Molina, A. et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 21(27), 4317\u20134322 (2002).","journal-title":"Oncogene"},{"issue":"11","key":"44542_CR5","doi-asserted-by":"publisher","first-page":"e7819","DOI":"10.1371\/journal.pone.0007819","volume":"4","author":"D Gallego-Ortega","year":"2009","unstructured":"Gallego-Ortega, D. et al. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment. PLoS One 4(11), e7819 (2009).","journal-title":"PLoS One"},{"issue":"11","key":"44542_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/j.1742-4658.2012.08573.x","volume":"279","author":"J Gruber","year":"2012","unstructured":"Gruber, J. et al. Balance of human choline kinase isoforms is critical for cell cycle regulation: Implications for the development of choline kinase-targeted cancer therapy. FEBS J. 279(11), 1915\u20131928 (2012).","journal-title":"FEBS J."},{"issue":"6","key":"44542_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/pharmaceutics13060911","volume":"13","author":"S Gokhale","year":"2021","unstructured":"Gokhale, S. & Xie, P. ChoK-full of potential: Choline kinase in B cell and T cell malignancies. Pharmaceutics 13(6), 911 (2021).","journal-title":"Pharmaceutics"},{"issue":"16","key":"44542_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jnci\/94.16.1197","volume":"94","author":"R Katz-Brull","year":"2002","unstructured":"Katz-Brull, R., Lavin, P. T. & Lenkinski, R. E. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J. Natl. Cancer Inst. 94(16), 1197\u20131203 (2002).","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"44542_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mrm.1183","volume":"46","author":"SJ Nelson","year":"2001","unstructured":"Nelson, S. J. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med. 46(2), 228\u2013239 (2001).","journal-title":"Magn Reson Med."},{"issue":"5","key":"44542_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s12551-020-00758-6","volume":"12","author":"U Sharma","year":"2020","unstructured":"Sharma, U. & Jagannathan, N. R. Metabolism of prostate cancer by magnetic resonance spectroscopy (MRS). Biophys Rev. 12(5), 1163\u20131173 (2020).","journal-title":"Biophys Rev."},{"issue":"6","key":"44542_CR11","first-page":"842","volume":"38","author":"T Hara","year":"1997","unstructured":"Hara, T., Kosaka, N., Sinoura, N. & Kondo, T. PET imaging of brain tumor with [methyl- 11C] choline. J. Nucl. Med. 38(6), 842\u2013847 (1997).","journal-title":"J. Nucl. Med."},{"issue":"Suppl 3","key":"44542_CR12","doi-asserted-by":"publisher","first-page":"38S","DOI":"10.2967\/jnumed.115.169748","volume":"57","author":"S Nitsch","year":"2016","unstructured":"Nitsch, S. et al. Evaluation of prostate cancer with 11C- and 18F-choline PET\/CT: Diagnosis and initial staging. J. Nucl. Med. 57(Suppl 3), 38S-42S (2016).","journal-title":"J. Nucl. Med."},{"issue":"16","key":"44542_CR13","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1158\/1078-0432.CCR-10-0468","volume":"16","author":"LM Kenny","year":"2010","unstructured":"Kenny, L. M. et al. Reproducibility of [11C]choline positron emission tomography and effect of trastuzumab. Clin. Cancer Res. 16(16), 4236\u20134245 (2010).","journal-title":"Clin. Cancer Res."},{"key":"44542_CR14","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/1078-0432.CCR-09-0666","volume":"15","author":"KB Contractor","year":"2009","unstructured":"Contractor, K. B. et al. [11C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin. Cancer Res. 15, 5503\u20135510 (2009).","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"44542_CR15","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1158\/1078-0432.CCR-11-2048","volume":"17","author":"K Contractor","year":"2011","unstructured":"Contractor, K. et al. Use of [11C]Choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin. Cancer Res. 17(24), 7673\u20137683 (2011).","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"44542_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1349-7006.2012.02348.x","volume":"103","author":"U Tateishi","year":"2012","unstructured":"Tateishi, U. et al. Comparative study of the value of dual tracer PET\/CT in evaluating breast cancer. Cancer Sci. 103(9), 1701\u20131707 (2012).","journal-title":"Cancer Sci."},{"issue":"4","key":"44542_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12149-010-0377-7","volume":"24","author":"H Fukukita","year":"2010","unstructured":"Fukukita, H. et al. Japanese guideline for the oncology FDG-PET\/CT data acquisition protocol: Synopsis of version 1.0. Ann. Nucl. Med. 24(4), 325\u2013334 (2010).","journal-title":"Ann. Nucl. Med."},{"issue":"3","key":"44542_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0969-8043(98)00097-9","volume":"50","author":"T Hara","year":"1999","unstructured":"Hara, T. & Yuasa, M. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging. Appl. Radiat. Isot. 50(3), 531\u2013533 (1999).","journal-title":"Appl. Radiat. Isot."},{"issue":"5","key":"44542_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston, C. W. & Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19(5), 403\u2013410 (1991).","journal-title":"Histopathology"},{"issue":"8 Suppl","key":"44542_CR20","first-page":"4244s","volume":"146","author":"KS McCarty","year":"1986","unstructured":"McCarty, K. S. et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 146(8 Suppl), 4244s\u20134248s (1986).","journal-title":"Cancer Res."},{"issue":"12","key":"44542_CR21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/cancers11121969","volume":"11","author":"M Grech-Sollars","year":"2019","unstructured":"Grech-Sollars, M. et al. Imaging and tissue biomarkers of choline metabolism in diffuse adult glioma: 18F-fluoromethylcholine PET\/CT, magnetic resonance spectroscopy, and choline kinase \u03b1. Cancers (Basel) 11(12), 1969 (2019).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"44542_CR22","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3892\/mmr.2015.3200","volume":"11","author":"Z Huang","year":"2015","unstructured":"Huang, Z., Rui, J., Li, X., Meng, X. & Liu, Q. Use of 11C-choline positron emission tomography\/computed tomography to investigate the mechanism of choline metabolism in lung cancer. Mol. Med. Rep. 11(5), 3285\u20133290 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"44542_CR23","doi-asserted-by":"publisher","first-page":"e46591","DOI":"10.1371\/journal.pone.0046591","volume":"7","author":"SA Kwee","year":"2012","unstructured":"Kwee, S. A., Hernandez, B., Chan, O. & Wong, L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: Association with survival. PLoS One 7(10), e46591 (2012).","journal-title":"PLoS One"},{"issue":"10","key":"44542_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1470-2045(07)70279-6","volume":"8","author":"A Ram\u00edrez de Molina","year":"2007","unstructured":"Ram\u00edrez de Molina, A. et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: A retrospective study. Lancet Oncol. 8(10), 889\u2013897 (2007).","journal-title":"Lancet Oncol."},{"issue":"1","key":"44542_CR25","first-page":"25","volume":"22","author":"K Kitajima","year":"2019","unstructured":"Kitajima, K. et al. Prognostic value of 18F-FDG PET\/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging. Hell. J. Nucl. Med. 22(1), 25\u201335 (2019).","journal-title":"Hell. J. Nucl. Med."},{"key":"44542_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejrad.2018.05.014","volume":"105","author":"W Diao","year":"2018","unstructured":"Diao, W., Tian, F. & Jia, Z. The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET\/CT in patients with breast cancer. Eur. J. Radiol. 105, 1\u20137 (2018).","journal-title":"Eur. J. Radiol."},{"issue":"12","key":"44542_CR27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2967\/jnumed.118.211102","volume":"59","author":"LM Peterson","year":"2018","unstructured":"Peterson, L. M. et al. Prospective study of serial 18F-FDG PET and 18F-Fluoride PET to predict time to skeletal-related events, time to progression, and survival in patients with bone-dominant metastatic breast cancer. J. Nucl. Med. 59(12), 1823\u20131830 (2018).","journal-title":"J. Nucl. Med."},{"issue":"11","key":"44542_CR28","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/modpathol.3800208","volume":"17","author":"M Mirlacher","year":"2004","unstructured":"Mirlacher, M. et al. Influence of slide aging on results of translational research studies using immunohistochemistry. Mod. Pathol. 17(11), 1414\u20131420 (2004).","journal-title":"Mod. Pathol."},{"issue":"4","key":"44542_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1055-9965.667.13.4","volume":"13","author":"JH Fergenbaum","year":"2004","unstructured":"Fergenbaum, J. H. et al. Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol. Biomark. Prev. 13(4), 667\u2013672 (2004).","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44542-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44542-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44542-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:25:33Z","timestamp":1700267133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44542-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44542-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17620"}}